share_log

NeuroSense Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ariel Gordon.(6.9%)

SEC announcement ·  Feb 13 13:25
Summary by Moomoo AI
On December 31, 2023, Ariel Gordon filed an amendment to Schedule 13G/A with the United States Securities and Exchange Commission, disclosing a 6.9% ownership stake in NeuroSense Therapeutics Ltd., which includes warrants to purchase 25,954 ordinary shares. The filing indicates that Gordon now beneficially owns 1,060,561 shares in the biotechnology company, based on 15,379,042 ordinary shares outstanding as provided by NeuroSense Therapeutics. The address for NeuroSense Therapeutics' principal executive offices is listed as 11 Hamenofim Street, Herzliya, Israel. Ariel Gordon, who holds both Israeli and U.S. citizenship, has sole voting and dispositive power over the shares. The filing was completed on February 13, 2024, and asserts that the acquisition of the shares is not for the purpose of changing or influencing the control of the issuer, nor is it in connection with any transaction having that purpose or effect.
On December 31, 2023, Ariel Gordon filed an amendment to Schedule 13G/A with the United States Securities and Exchange Commission, disclosing a 6.9% ownership stake in NeuroSense Therapeutics Ltd., which includes warrants to purchase 25,954 ordinary shares. The filing indicates that Gordon now beneficially owns 1,060,561 shares in the biotechnology company, based on 15,379,042 ordinary shares outstanding as provided by NeuroSense Therapeutics. The address for NeuroSense Therapeutics' principal executive offices is listed as 11 Hamenofim Street, Herzliya, Israel. Ariel Gordon, who holds both Israeli and U.S. citizenship, has sole voting and dispositive power over the shares. The filing was completed on February 13, 2024, and asserts that the acquisition of the shares is not for the purpose of changing or influencing the control of the issuer, nor is it in connection with any transaction having that purpose or effect.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more